| For: | Grozinsky-Glasberg S, Thomas D, Strosberg JR, Pape UF, Felder S, Tsolakis AV, Alexandraki KI, Fraenkel M, Saiegh L, Reissman P, Kaltsas G, Gross DJ. Metastatic type 1 gastric carcinoid: A real threat or just a myth? World J Gastroenterol 2013; 19(46): 8687-8695 [PMID: 24379587 DOI: 10.3748/wjg.v19.i46.8687] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i46/8687.htm |
| Number | Citing Articles |
| 1 |
Duan Chen, Susan J. Hagen, Malcolm Boyce, Chun‐Mei Zhao. Neuroendocrine mechanism of gastric acid secretion: Historical perspectives and recent developments in physiology and pharmacology. Journal of Neuroendocrinology 2023; 35(11) doi: 10.1111/jne.13305
|
| 2 |
Evita Henderson-Jackson, Ujalla Sheikh, Jalil Muhammad, Domenico Coppola, Aejaz Nasir. Neuroendocrine Tumors: Review of Pathology, Molecular and Therapeutic Advances. 2016; doi: 10.1007/978-1-4939-3426-3_12
|
| 3 |
A. Malczewska, A. Procner, A. Walter, K. Kusnierz, W. Zajecki, H. Aslanian, B. Kos-Kudla. The NETest liquid biopsy is diagnostic for gastric neuroendocrine tumors: observations on the blood-based identification of microscopic and macroscopic residual disease. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01348-2
|
| 4 |
Marina Tsoli, Eleftherios Chatzellis, Anna Koumarianou, Dionysia Kolomodi, Gregory Kaltsas. Current best practice in the management of neuroendocrine tumors. Therapeutic Advances in Endocrinology and Metabolism 2019; 10 doi: 10.1177/2042018818804698
|
| 5 |
Joana Carvão, Mário Dinis-Ribeiro, Pedro Pimentel-Nunes, Diogo Libânio. Neuroendocrine Tumors of the Gastrointestinal Tract: A Focused Review and Practical Approach for Gastroenterologists. GE - Portuguese Journal of Gastroenterology 2021; 28(5) doi: 10.1159/000512089
|
| 6 |
Liv Sagatun, Patricia Mjønes, Constantin S. Jianu, Malcolm Boyce, Hege L. Waldum, Reidar Fossmark. The gastrin receptor antagonist netazepide (YF476) in patients with type 1 gastric enterochromaffin-like cell neuroendocrine tumours: review of long-term treatment. European Journal of Gastroenterology & Hepatology 2016; 28(11) doi: 10.1097/MEG.0000000000000713
|
| 7 |
Mesut Sezikli, Tolga Duzenli, Hüseyin Köseoğlu. Gastric neuroendocrine neoplasms: A review. World Journal of Clinical Cases 2021; 9(27): 7973-7985 doi: 10.12998/wjcc.v9.i27.7973
|
| 8 |
Oriol Calvete, Jose Reyes, Sheila Zuñiga, Beatriz Paumard-Hernández, Victoria Fernández, Luís Bujanda, María S. Rodriguez-Pinilla, Jose Palacios, Damian Heine-Suñer, Siddharth Banka, William G. Newman, Marta Cañamero, D. Mark Pritchard, Javier Benítez. Exome sequencing identifies ATP4A gene as responsible of an atypical familial type I gastric neuroendocrine tumour. Human Molecular Genetics 2015; 24(10) doi: 10.1093/hmg/ddv054
|
| 9 |
Zhi-hao Yang, Yi-jing Han, Ming Cheng, Rui Wang, Jing Li, Hui-ping Zhao, Jian-bo Gao. Prognostic value of computed tomography radiomics features in patients with gastric neuroendocrine neoplasm. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1143291
|
| 10 |
Michael Rassner, Harald Lahner, Nikolas von Bubnoff, Frank Lammert. Geriatrische Onkologie. 2018; doi: 10.1007/978-3-662-48727-3_30
|
| 11 |
Tanya Odisho, Dongping Shi, Ahmad Aburashed. Successful endoscopic resection of an unusually enlarged and pedunculated type I gastric carcinoid tumour. BMJ Case Reports 2021; 14(8) doi: 10.1136/bcr-2021-244292
|
| 12 |
Apostolos V. Tsolakis. Encyclopedia of Endocrine Diseases. 2019; doi: 10.1016/B978-0-443-13825-6.00402-7
|
| 13 |
Sandip Pal, Digvijay Hodgar. Gastrointestinal Subepithelial Lesions: A Review. Journal of Digestive Endoscopy 2023; 14(02) doi: 10.1055/s-0043-1770923
|
| 14 |
Sara Massironi, Alessandra Zilli, Dario Conte. Somatostatin analogs for gastric carcinoids: For many, but not all. World Journal of Gastroenterology 2015; 21(22): 6785-6793 doi: 10.3748/wjg.v21.i22.6785
|
| 15 |
Davide Ravizza, Giancarla Fiori. Neuroendocrine Neoplasia Management. 2021; doi: 10.1007/978-3-030-72830-4_13
|
| 16 |
Gregory Kaltsas, Simona Grozinsky‐Glasberg, Krystallenia I. Alexandraki, Dimitrios Thomas, Apostolos V. Tsolakis, David Gross, Ashley B. Grossman. Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms. Clinical Endocrinology 2014; 81(2) doi: 10.1111/cen.12476
|
| 17 |
Ken Namikawa, Tomoari Kamada, Junko Fujisaki, Yuichi Sato, Takahisa Murao, Tsutomu Chiba, Yasuharu Kaizaki, Kenji Ishido, Yutaro Ihara, Koichi Kurahara, Tomoaki Suga, Haruhisa Suzuki, Masanori Ito, Katsuya Hirakawa, Yasuhiko Maruyama, Takuji Gotoda, Osamu Hosokawa, Tomohiro Koike, Katsuhiro Mabe, Takashi Yao, Kazuo Inui, Hiroyasu Iishi, Haruhiko Ogata, Takahisa Furuta, Ken Haruma. Clinical characteristics and long‐term prognosis of type 1 gastric neuroendocrine tumors in a large Japanese national cohort. Digestive Endoscopy 2023; 35(6) doi: 10.1111/den.14529
|
| 18 |
Yoshihito SHINOHARA, Takahiro TSUCHIKAWA, Yuma EBIHARA, Toshiaki SHICHINOHE, Satoshi HIRANO. Clinical Experience with Treatments of Gastric Neuroendocrine Neoplasms. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2022; 83(2) doi: 10.3919/jjsa.83.263
|
| 19 |
Elisabeth Maurer, Ulrike Denzer, Detlef K. Bartsch. Neuroendokrine Neoplasien des Magens: Update endoskopische und chirurgische Therapie. Die Chirurgie 2026; doi: 10.1007/s00104-026-02511-3
|
| 20 |
Bernardo Marques, Raquel G Martins, Guilherme Tralhão, Joana Couto, Sandra Saraiva, Henrique Ferrão, João Ribeiro, Jacinta Santos, Teresa Martins, Ana Teresa Cadime, Fernando Rodrigues. Gastric neuroendocrine neoplasm with late liver metastasis. Endocrinology, Diabetes & Metabolism Case Reports 2018; 2018 doi: 10.1530/EDM-18-0048
|
| 21 |
Francesco Panzuto, Dermot O'Toole, Günter Klöppel, Ulrich Peter Knigge, Günter Josef Krejs, Marina Tsoli, Marco Volante, Tu Vinh Luong. Controversies in NEN: An ENETS position statement on the endoscopic management of localised gastric, duodenal and rectal neuroendocrine neoplasms. Journal of Neuroendocrinology 2025; 37(12) doi: 10.1111/jne.70060
|
| 22 |
Andrea Grin, Catherine J. Streutker. Neuroendocrine Tumors of the Luminal Gastrointestinal Tract. Archives of Pathology & Laboratory Medicine 2015; 139(6) doi: 10.5858/arpa.2014-0130-RA
|
| 23 |
Noble Varghese Mathews, Sudipta Dhar Chowdhury, Anoop John. Endoscopy in the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors. Gastroenterology, Hepatology and Endoscopy Practice 2024; 4(1) doi: 10.4103/ghep.ghep_21_23
|
| 24 |
Chen-Shuan Chung, Cho-Lun Tsai, Yin-Yi Chu, Kuan-Chih Chen, Jung-Chun Lin, Bao-Chung Chen, Wei-Chih Sun, Hsu-Heng Yen, Chiung-Yu Chen, I-Chen Wu, Chao-Hung Kuo, Hisang-Yao Shih, Ming-Jong Bair, Jack P. Wang, Wen-Hao Hu, Chang-Shyue Yang, Ming-Lun Han, Tsu-Yao Cheng, Chao-Ming Tseng, Ming-Chang Tsai, Ming-Luen Hu, Hsiu-Po Wang. Clinical features and outcomes of gastric neuroendocrine tumors after endoscopic diagnosis and treatment. Medicine 2018; 97(38) doi: 10.1097/MD.0000000000012101
|
| 25 |
Elisabetta Dell’Unto, Maria Rinzivillo, Gianluca Esposito, Elsa Iannicelli, Daniela Prosperi, Francesco Panzuto, Bruno Annibale. Metastatic Type 1 low-grade gastric neuroendocrine tumor treated with peptide receptor radionuclide therapy in a young adult: a case report. Gastroenterology Report 2023; 12 doi: 10.1093/gastro/goae023
|
| 26 |
Natalie Patel, Andrea Barbieri, Joanna Gibson. Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas. Surgical Pathology Clinics 2019; 12(4) doi: 10.1016/j.path.2019.08.007
|
| 27 |
Valentina Andreasi, Stefano Partelli, Francesca Muffatti, Marco F. Manzoni, Gabriele Capurso, Massimo Falconi. Update on gastroenteropancreatic neuroendocrine tumors. Digestive and Liver Disease 2021; 53(2) doi: 10.1016/j.dld.2020.08.031
|
| 28 |
Lauren M. Postlewait, Gillian G. Baptiste, Cecilia G. Ethun, Nina Le, Kenneth Cardona, Maria C. Russell, Field F. Willingham, David A. Kooby, Charles A. Staley, Shishir K. Maithel. A 15-year experience with gastric neuroendocrine tumors: Does type make a difference?. Journal of Surgical Oncology 2016; 114(5) doi: 10.1002/jso.24369
|
| 29 |
|
| 30 |
Mohammad Sheikh-Ahmad, Leonard Saiegh, Anan Shalata, Jacob Bejar, Hila Kreizman-Shefer, Majd F. Sirhan, Ibrahim Matter, Forat Swaid, Monica Laniado, Nama Mubariki, Tova Rainis, Ilana Rosenblatt, Ekaterina Yovanovich, Abed Agbarya. Factors Predicting Type I Gastric Neuroendocrine Neoplasia Recurrence: A Single-Center Study. Biomedicines 2023; 11(3) doi: 10.3390/biomedicines11030828
|
| 31 |
Katie A. Lloyd, Bryony N. Parsons, Michael D. Burkitt, Andrew R. Moore, Stamatia Papoutsopoulou, Malcolm Boyce, Carrie A. Duckworth, Klaire Exarchou, Nathan Howes, Lucille Rainbow, Yongxiang Fang, Claus Oxvig, Steven Dodd, Andrea Varro, Neil Hall, D. Mark Pritchard. Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors. Cellular and Molecular Gastroenterology and Hepatology 2020; 10(1) doi: 10.1016/j.jcmgh.2020.01.010
|
| 32 |
R. Basuroy, R. Srirajaskanthan, A. Prachalias, A. Quaglia, J. K. Ramage. Review article: the investigation and management of gastric neuroendocrine tumours. Alimentary Pharmacology & Therapeutics 2014; 39(10) doi: 10.1111/apt.12698
|
| 33 |
Ivan Borbath, Ulrich‐Frank Pape, Pierre H. Deprez, Detlef Klaus Bartsch, Martyn Caplin, Massimo Falconi, Rocio Garcia‐Carbonero, Simona Grozinsky‐Glasberg, Robert T. Jensen, Rudolf Arnold, Philippe Ruszniewski, C. Toumpanakis, Juan W. Valle, Dermot O´Toole. ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors. Journal of Neuroendocrinology 2022; 34(3) doi: 10.1111/jne.13105
|
| 34 |
Brent K. Larson, Deepti Dhall. Practical Gastrointestinal Pathology. 2021; doi: 10.1007/978-3-030-51268-2_17
|
| 35 |
Jin Hee Noh, Do Hoon Kim, Hwan Yoon, Li-Chang Hsing, Hee Kyong Na, Ji Yong Ahn, Jeong Hoon Lee, Kee Wook Jung, Kee Don Choi, Ho June Song, Gin Hyug Lee, Hwoon-Yong Jung. Clinical Outcomes of Endoscopic Treatment for Type 1 Gastric Neuroendocrine Tumor. Journal of Gastrointestinal Surgery 2021; 25(10) doi: 10.1007/s11605-021-04997-0
|
| 36 |
Malcolm Boyce, Andrew R. Moore, Liv Sagatun, Bryony N. Parsons, Andrea Varro, Fiona Campbell, Reidar Fossmark, Helge L. Waldum, D. Mark Pritchard. Netazepide, a gastrin/cholecystokinin‐2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis. British Journal of Clinical Pharmacology 2017; 83(3) doi: 10.1111/bcp.13146
|
| 37 |
Cemal Yazici, Brian R Boulay. Evolving role of the endoscopist in management of gastrointestinal neuroendocrine tumors. World Journal of Gastroenterology 2017; 23(27): 4847-4855 doi: 10.3748/wjg.v23.i27.4847
|
| 38 |
Xinrui Guo, Xiaohan Zhao, Gang Huang, Yanbo Yu. Advances in Endoscopic Diagnosis and Treatment of Gastric Neuroendocrine Neoplasms. Digestive Diseases and Sciences 2024; 69(1) doi: 10.1007/s10620-023-08180-0
|
| 39 |
Johannes Hofland, Gregory Kaltsas, Wouter W de Herder. Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms. Endocrine Reviews 2020; 41(2) doi: 10.1210/endrev/bnz004
|
| 40 |
S. Maasberg, C. Jürgensen, F. Scheerer, R. Pschowski, S. Felder, N. Begum, B. Wiedenmann, A. Pascher, U.-F. Pape. Endoskopische Therapie gastroduodenaler neuroendokriner Neoplasien. Der Chirurg 2016; 87(4) doi: 10.1007/s00104-016-0157-6
|
| 41 |
Francesco Panzuto, Sara Massironi, Stefano Partelli, Davide Campana, Maria Rinzivillo, Pietro Invernizzi, Valentina Andreasi, Giuseppe Lamberti, Massimo Falconi. Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management. Surgical Oncology 2020; 35 doi: 10.1016/j.suronc.2020.08.015
|
| 42 |
Apostolos V. Tsolakis. Encyclopedia of Endocrine Diseases. 2019; doi: 10.1016/B978-0-12-801238-3.66115-9
|
| 43 |
Yuichi Sato. Clinical features and management of type I gastric carcinoids. Clinical Journal of Gastroenterology 2014; 7(5) doi: 10.1007/s12328-014-0528-9
|
| 44 |
Pierre H. Deprez, Leon M.G. Moons, Dermot OʼToole, Rodica Gincul, Andrada Seicean, Pedro Pimentel-Nunes, Gloria Fernández-Esparrach, Marcin Polkowski, Michael Vieth, Ivan Borbath, Tom G. Moreels, Els Nieveen van Dijkum, Jean-Yves Blay, Jeanin E. van Hooft. Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2022; 54(04) doi: 10.1055/a-1751-5742
|
| 45 |
Jin Ook Jang, Won Jun Jang, Cheol Woong Choi, Eun Jeung Choi, Su Jin Kim, Dae Gon Ryu, Su Bum Park, Jae Hun Chung, Si Hak Lee, Sun Hwi Hwang. A single center retrospective analysis of feasibility of diagnostic endoscopic resection for grade 1 or 2 gastric neuroendocrine tumors. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-99791-2
|
| 46 |
Laura Baldini, Elisabetta Dell'Unto, Maria Rinzivillo, Gianluca Esposito, Francesco Panzuto. Step‐by‐Step Approach to the Incidental Diagnosis of Type I Gastric Neuroendocrine Tumors: Practical Insights. JGH Open 2025; 9(9) doi: 10.1002/jgh3.70260
|
| 47 |
Sara Massironi, Alessandra Zilli, Ilaria Fanetti, Clorinda Ciafardini, Dario Conte, Maddalena Peracchi. Intermittent treatment of recurrent type-1 gastric carcinoids with somatostatin analogues in patients with chronic autoimmune atrophic gastritis. Digestive and Liver Disease 2015; 47(11) doi: 10.1016/j.dld.2015.07.155
|
| 48 |
Alessandro Vanoli, Stefano La Rosa, Emanuela Miceli, Catherine Klersy, Roberta Maragliano, Francesca Capuano, Andrea Persichella, Michele Martino, Frediano Inzani, Ombretta Luinetti, Antonio Di Sabatino, Fausto Sessa, Marco Paulli, Gino Roberto Corazza, Guido Rindi, Cesare Bordi, Carlo Capella, Enrico Solcia. Prognostic Evaluations Tailored to Specific Gastric Neuroendocrine Neoplasms: Analysis Of 200 Cases with Extended Follow-Up. Neuroendocrinology 2018; 107(2) doi: 10.1159/000489902
|
| 49 |
Hussein Nassereddine, Matthieu Chicaud, Khedidja Rebah, Nathalie Théou-Anton, Anne Sautet, Jacques Dermer, Anne Couvelard. Pathogenic ATM Variant-Harbouring Well-Differentiated Aggressive Type 1 Gastric Neuroendocrine Tumour with High-grade Features (G3 NET): a New Addition to the Clinical and Pathological Spectrum of Gastric Neuroendocrine Neoplasms. Endocrine Pathology 2021; 32(4) doi: 10.1007/s12022-021-09681-2
|
| 50 |
Günter Klöppel, Stefano La Rosa. Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms. Virchows Archiv 2018; 472(3) doi: 10.1007/s00428-017-2258-0
|
| 51 |
G. Delle Fave, D. O''Toole, A. Sundin, B. Taal, P. Ferolla, J.K. Ramage, D. Ferone, T. Ito, W. Weber, Z. Zheng-Pei, W.W. De Herder, A. Pascher, P. Ruszniewski. ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms. Neuroendocrinology 2016; 103(2) doi: 10.1159/000443168
|
| 52 |
Takaaki Arigami, Yoshikazu Uenosono, Shigehiro Yanagita, Keishi Okubo, Takashi Kijima, Daisuke Matsushita, Masahiko Amatatsu, Takahiko Hagihara, Naoto Haraguchi, Yuko Mataki, Katsuhiko Ehi, Sumiya Ishigami, Shoji Natsugoe. Sentinel node navigation surgery for gastroduodenal neuroendocrine tumors. Medicine 2016; 95(26) doi: 10.1097/MD.0000000000004063
|
| 53 |
Gurleen Pasricha, Parikshit Padhi, Nour Daboul, Dulabh K. Monga. Management of Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEPNETs): A Review. Clinical Therapeutics 2017; 39(11) doi: 10.1016/j.clinthera.2017.10.010
|
| 54 |
Apostolos V Tsolakis, Athanasia Ragkousi, Miroslav Vujasinovic, Gregory Kaltsas, Kosmas Daskalakis. Gastric neuroendocrine neoplasms type 1: A systematic review and meta-analysis. World Journal of Gastroenterology 2019; 25(35): 5376-5387 doi: 10.3748/wjg.v25.i35.5376
|
| 55 |
Klaire Exarchou, Haiyi Hu, Nathan A. Stephens, Andrew R. Moore, Mark Kelly, Angela Lamarca, Wasat Mansoor, Richard Hubner, Mairéad G. McNamara, Howard Smart, Nathan R. Howes, Juan W. Valle, D. Mark Pritchard. Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10 mm in diameter. Endocrine 2022; 78(1) doi: 10.1007/s12020-022-03143-3
|
| 56 |
Francesco Panzuto, Davide Campana, Sara Massironi, Antongiulio Faggiano, Maria Rinzivillo, Giuseppe Lamberti, Valentina Sciola, Edith Lahner, Lisa Manuzzi, Annamaria Colao, Bruno Annibale. Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: A multicentre retrospective study. Digestive and Liver Disease 2019; 51(10) doi: 10.1016/j.dld.2019.04.016
|
| 57 |
Roberta Elisa Rossi, Pietro Invernizzi, Vincenzo Mazzaferro, Sara Massironi. Response and relapse rates after treatment with long‐acting somatostatin analogs in multifocal or recurrent type‐1 gastric carcinoids: A systematic review and meta‐analysis. United European Gastroenterology Journal 2020; 8(2) doi: 10.1177/2050640619890465
|
| 58 |
Liv Sagatun, Reidar Fossmark, Constantin S. Jianu, Gunnar Qvigstad, Ivar S. Nordrum, Patricia Mjønes, Helge L. Waldum. Follow-up of patients with ECL cell-derived tumours. Scandinavian Journal of Gastroenterology 2016; 51(11) doi: 10.3109/00365521.2016.1169588
|
| 59 |
Gianluca Esposito, Emanuele Dilaghi, Maria Cazzato, Emanuela Pilozzi, Laura Conti, Marilia Carabotti, Emilio Di Giulio, Bruno Annibale, Edith Lahner. Endoscopic surveillance at 3 years after diagnosis, according to European guidelines, seems safe in patients with atrophic gastritis in a low-risk region. Digestive and Liver Disease 2021; 53(4) doi: 10.1016/j.dld.2020.10.038
|
| 60 |
|
| 61 |
Dou Dou, Yan-Fen Shi, Qing Liu, Jie Luo, Ji-Xi Liu, Meng Liu, Ying-Ying Liu, Yuan-Liang Li, Xu-Dong Qiu, Huang-Ying Tan. Hsa-miR-202-3p, up-regulated in type 1 gastric neuroendocrine neoplasms, may target <i>DUSP1</i>. World Journal of Gastroenterology 2018; 24(5): 573-582 doi: 10.3748/wjg.v24.i5.573
|
| 62 |
Yuki Morita, Ken Namikawa, Kaoru Nakano, Wataru Kurihara, Hiroyuki Yamamoto, Yusuke Horiuchi, Akiyoshi Ishiyama, Toshiyuki Yoshio, Souya Nunobe, Toshiaki Hirasawa. Clinical Outcomes of Antrectomy for Patients With Multiple Type I Gastric Neuroendocrine Tumors: A Case Series. DEN Open 2027; 7(1) doi: 10.1002/deo2.70363
|
| 63 |
Maria Rinzivillo, Francesco Panzuto, Gianluca Esposito, Edith Lahner, Alberto Signore, Bruno Annibale. Usefulness of 68-Gallium PET in Type I Gastric Neuroendocrine Neoplasia: A Case Series. Journal of Clinical Medicine 2022; 11(6) doi: 10.3390/jcm11061641
|
| 64 |
Gianluca Esposito, Maria Cazzato, Maria Rinzivillo, Emanuela Pilozzi, Edith Lahner, Bruno Annibale, Francesco Panzuto. Management of type-I gastric neuroendocrine neoplasms: A 10-years prospective single centre study. Digestive and Liver Disease 2022; 54(7) doi: 10.1016/j.dld.2021.11.012
|
| 65 |
O Kurtulan, N Turhan, G Gedikoğlu, A Akyol, C Sökmensüer. Defining prognostic parameters of well-differentiated gastric neuroendocrine tumors based on metastatic potential: a two-center experience. Acta Gastro Enterologica Belgica 2022; 85(2) doi: 10.51821/85.2.8601
|
| 66 |
Davide Campana, Nico Pagano, Nicole Brighi, Dario Fabbri, Maria Rinzivillo, Gianfranco Delle Fave, Guido Biasco, Francesco Panzuto. Neuroendocrine Tumors in Real Life. 2018; doi: 10.1007/978-3-319-59024-0_16
|
| 67 |
Taymeyah Al-Toubah, Eleonora Pelle, Mintallah Haider, Jonathan Strosberg. Association Between Long-Term Proton Pump Inhibitor Use and Low-Risk Gastric Neuroendocrine Tumors. Annals of Surgical Oncology 2026; 33(1) doi: 10.1245/s10434-025-18430-2
|
| 68 |
|
| 69 |
Davide Ravizza, Mariangela Giunta, Isabella Sala, Vincenzo Bagnardi, Darina Tamayo, Giuseppe de Roberto, Cristina Trovato, Ivana Bravi, Pietro Soru, Margherita Maregatti, Eleonora Pisa, Emilio Bertani, Guido Bonomo, Francesca Spada, Fazio Nicola. Gastric neuroendocrine tumors: 20‐Year experience in a reference center. Journal of Neuroendocrinology 2024; 36(12) doi: 10.1111/jne.13440
|
| 70 |
Michael Rassner, Harald Lahner, Nikolas von Bubnoff, Frank Lammert. Geriatrische Onkologie. 2017; doi: 10.1007/978-3-662-49083-9_30-1
|
| 71 |
Elisabetta Dell’Unto, Maria Rinzivillo, Gianluca Esposito, Francesco Panzuto. Incidental Gastric Neuroendocrine Tumor on Histology: What Should the Gastroenterologist Do Next?. Gastroenterology Insights 2026; 17(2) doi: 10.3390/gastroent17020028
|
| 72 |
Simona Grozinsky-Glasberg, Krystallenia I. Alexandraki, Anna Angelousi, Eleftherios Chatzellis, Stavros Sougioultzis, Gregory Kaltsas. Gastric Carcinoids. Endocrinology and Metabolism Clinics of North America 2018; 47(3) doi: 10.1016/j.ecl.2018.04.013
|
| 73 |
Francesco Panzuto, Ludovica Magi, Gianluca Esposito, Maria Rinzivillo, Bruno Annibale, Fabiana Zingone. Comparison of Endoscopic Techniques in the Management of Type I Gastric Neuroendocrine Neoplasia: A Systematic Review. Gastroenterology Research and Practice 2021; 2021 doi: 10.1155/2021/6679397
|
| 74 |
Safak Gül-Klein, Alexander Arnold, Christian Oberender, Matylda Zofia Kuzinska, Miguel Enrique Alberto Vilchez, Martina T. Mogl, Beate Rau. Appendixneoplasien. coloproctology 2023; 45(2) doi: 10.1007/s00053-023-00686-5
|
| 75 |
Xiaoxiao Jiao, Zhaodi Wang, Xiaoqian Peng, Lianfeng Zhang, Lin Zhou. Effects of tumor types on treatment strategy formulation and prognostic evaluation of gastric neuroendocrine tumors. Future Oncology 2020; 16(28) doi: 10.2217/fon-2020-0150
|
| 76 |
Rebecca M. Haug, Darius A. Jahann, Vanessa M. Shami. A Practical Approach to the Management of Incidentally Found Gastrointestinal Neuroendocrine Tumors. American Journal of Gastroenterology 2024; 119(10) doi: 10.14309/ajg.0000000000002825
|